Phoslo and Erythromycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phoslo (calcium acetate) and Erythromycin (erythromycin). Common drug interactions include renal failure chronic among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Phoslo and Erythromycin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Phoslo?

Phoslo has active ingredients of calcium acetate. eHealthMe is studying from 4,291 Phoslo users. Check the latest studies of Phoslo.

What is Erythromycin?

Erythromycin has active ingredients of erythromycin. It is often used in acne. eHealthMe is studying from 12,563 Erythromycin users. Check the latest studies of Erythromycin.



On Aug, 09, 2026

23 people who take Phoslo and Erythromycin together, and have interactions are studied.

Phoslo and Erythromycin drug interactions.

What are the common drug interactions of Phoslo and Erythromycin, by gender? *:

female:

  1. Renal failure chronic (long lasting kidney dysfunction)
  2. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  3. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  4. Hyperlipidaemia (presence of excess lipids in the blood)
  5. Hypertension (high blood pressure)
  6. Lethargy (tiredness)
  7. Surgery
  8. Asthenia (weakness)
  9. Cardiac murmur (an heart sound in valve abnormality)
  10. Cardioactive drug level increased

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Procedural pain
  3. Hypertension (high blood pressure)
  4. Impaired gastric emptying
  5. Pain
  6. Anaphylactic reaction (serious allergic reaction)
  7. Anger
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Anxiety
  10. Aphagia (inability or refusal to swallow)

What are the common drug interactions of Phoslo and Erythromycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anger
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Aphagia (inability or refusal to swallow)
  5. Aphasia (damage to the parts of the brain that control language)
  6. Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
  7. Depression
  8. Dyskinesia (abnormality or impairment of voluntary movement)
  9. Emotional distress
  10. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Procedural pain
  3. Abdominal distension
  4. Anaemia (lack of blood)
  5. Anaphylactic reaction (serious allergic reaction)
  6. Asthma
  7. Blood glucose decreased
  8. Blood pressure systolic increased
  9. Depression
  10. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)

50-59:

  1. Nephropathy (damage to or disease of a kidney)
  2. Nerve injury
  3. Osteopenia (a condition where bone mineral density is lower than normal)
  4. Pancreatitis acute (sudden inflammation of pancreas)
  5. Pancreatitis chronic (chronic inflammation of pancreas)
  6. Renal injury (kidney injury)
  7. Weight decreased
  8. Renal failure (kidney dysfunction)
  9. Chronic kidney disease
  10. Nephrogenic anaemia (anaemia due to kidney disease)

60+:

  1. Anxiety
  2. Anaemia (lack of blood)
  3. Cardioactive drug level increased
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Diarrhoea
  6. Hypertension (high blood pressure)
  7. Hypophagia (reduced food intake)
  8. Impaired healing
  9. Unresponsive to stimuli
  10. Abdominal distension

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 3 people, 13.04%
  2. High Blood Pressure: 3 people, 13.04%
  3. Phosphorus Metabolism Disorder: 2 people, 8.70%
  4. Pain: 2 people, 8.70%
  5. Nuclear Magnetic Resonance Imaging Abdominal: 2 people, 8.70%
  6. High Blood Cholesterol: 2 people, 8.70%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.70%
  8. Chronic Renal Failure (kidney failure): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Phoslo and Erythromycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phoslo and Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phoslo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Erythromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on calcium acetate and erythromycin (the active ingredients of Phoslo and Erythromycin, respectively), and Phoslo and Erythromycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: